Dasotraline Pediatric Extension Study

PHASE3CompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 2, 2017

Study Completion Date

February 2, 2017

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Dasotraline

Dasotraline 2 mg, 4 mg, 6 mg, once daily, flexibly dosed

Trial Locations (36)

10312

Richarmond Behavioral Associates, Staten Island

29464

Coastal Carolina Research Center, Mt. Pleasant

30030

iResearch Atlanta, LLC, Decatur

30331

Atlanta Center for Medical Research, Atlanta

32256

Clinical Neuroscience Solutions, Inc, Jacksonville

32607

Sarkis Clinical Trials, Gainesville

32751

Florida Clinical Research Center, LLC, Maitland

32801

Clinical Neuroscience Solutions, Inc., Orlando

33012

Indago Research Health Center, Inc., Hialeah

33143

Miami Research Associates, LLC, South Miami

36303

Harmonex Neuroscience Research, Inc, Dothan

42301

Pedia Research,LLC, Owensboro

44106

University Hospitals Case Medical Center, Cleveland

45219

University of Cincinnati/Department of Psychiatry and Behavioral Neuroscience, Cincinnati

46260

Goldpoint Clinical Research, LLC., Indianapolis

47630

Pedia Research,LLC, Newburgh

48302

Neurobehavioral Medicine Group, Clinical Trials Division, Bloomfield Hills

48307

Clinical Trials group at the Rochester Center for Behavioral Medicine, Rochester Hills

60418

Capstone Clinical Research, Libertyville

63304

St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles

66211

Psychiatric Associates, Overland Park

73103

IPS Research Company, Oklahoma City

73116

Cutting Edge Research Group, Oklahoma City

77007

Bayou City Research, Ltd., Houston

77098

Houston Clinical Trials, LLC, Houston

77381

Family Psychiatry of the Woodlands, The Woodlands

78229

Clinical Trials of Texas, Inc., San Antonio

78258

Road Runner Research, Ltd., San Antonio

78759

BioBehavioral Research of Austin P.C., Austin

80910

MCB Clinical Research Centers, LLC, Colorado Springs

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

90230

ProScience Research Group, Culver City

92595

Elite Clinical Trials, Inc., Wildomar

97030

Cyn3rgy Research, Gresham

630-896-3530

Baber Research Group, Inc., Naperville

08053

Pharmaceutical Research Associates, Inc., Marlton

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT02457819 - Dasotraline Pediatric Extension Study | Biotech Hunter | Biotech Hunter